When you get a flu shot or other vaccination, it is normal to experience mild pain at the injection site. But, what if your pain lingers? What if it gets worse over time? What if you start to experience other effects, such as reduced strength or limited mobility in your shoulder? These are all possible symptoms of a class of injuries known as “shoulder injury related to vaccine administration,” or “SIRVA.”
Unlike other common vaccine injuries, SIRVA do not result from adverse reactions to particular vaccine ingredients. Instead, they result from damage to the muscle or other tissue in the shoulder as a result of mistakes made during the vaccination process. This includes mistakes such as inserting the needle in the wrong location, inserting the needle at the wrong angle and using a needle that is the wrong size for the vaccine recipient’s sex and weight. Continue reading
If you have been diagnosed with a vaccine-related injury, including a Shoulder Injury Related to Vaccine Administration (SIRVA), you may be entitled to recover your medical expenses and certain other losses under the National Vaccine Injury Compensation Program (VICP). Here are 10 key facts about filing a claim under the VICP:
Shoulder Injury Related to Vaccine Administration (SIRVA) can take a variety of forms, each with its own effects and long-term prognosis. While most people diagnosed with SIRVA will eventually recover, recovery options vary, and a person’s individual health profile can have a significant impact on the challenges, costs and duration of the recovery process.
With vaccine injections, it is normal to experience acute stinging or dull pain that dissipates in the hours following the vaccination. It is not normal for this pain to linger, worsen or spread to other parts of the arm or shoulder. Unfortunately, while this pain is not normal, studies show that it is becoming 
“Any vaccine can cause side effects.” While all vaccines recommended for use in the U.S. are considered safe for the vast majority of the population (with exceptions for individuals with certain medical conditions), the Centers for Disease Control and Prevention (CDC) wants vaccine recipients to be aware that certain 
The Food and Drug Administration (FDA) has approved a new vaccine that is being billed as “six vaccines in one.” As reported by 
In late 2018, the U.S. Food and Drug Administration (FDA) announced expanded approval of the Gardasil 9 human papilloma virus (HPV) vaccine. Previously approved for administration to males and females between the ages of 9 and 26, Gardasil 9 is now an approved HPV vaccine for men and women through 45 years of age.
The Centers for Disease Control and Prevention (CDC) recommend an annual flu shot for everyone beginning at six months of age, subject to limited exceptions for individuals who present certain risk factors. The general recommendation to get vaccinated includes women who are pregnant. According to the CDC:
According to a